These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 4462871

  • 21. Mortality among Parkinson patients treated with L-dopa combined with a decarboxylase inhibitor.
    Zumstein H, Siegfried J.
    Eur Neurol; 1976; 14(5):321-8. PubMed ID: 949985
    [Abstract] [Full Text] [Related]

  • 22. [Decarboxylase inhibitor given in combination with l-dopa. A new therapeutic principal in parkinsonism].
    Dietrichson P.
    Tidsskr Nor Laegeforen; 1973 Oct 10; 93(28):2113-5. PubMed ID: 4590070
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Levodopa with benserazide or carbidopa in Parkinson disease.
    Rinne UK, Mölsä P.
    Neurology; 1979 Dec 10; 29(12):1584-9. PubMed ID: 574221
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Comparison of levodopa with carbidopa or benserazide in parkinsonism.
    Greenacre JK, Coxon A, Petrie A, Reid JL.
    Lancet; 1976 Aug 21; 2(7982):381-4. PubMed ID: 73849
    [Abstract] [Full Text] [Related]

  • 29. Madopar HBS in fluctuating parkinsonian patients: two-year treatment.
    Pezzoli G, Tesei S, Ferrante C, Cossutta E, Zecchinelli A, Scarlato G.
    Mov Disord; 1988 Aug 21; 3(1):37-45. PubMed ID: 3050471
    [Abstract] [Full Text] [Related]

  • 30. [Combined (surgical and drug) therapy of parkinsonism].
    Kandel' EI, Iadgarov IS.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984 Aug 21; 84(8):1157-61. PubMed ID: 6388198
    [Abstract] [Full Text] [Related]

  • 31. [Analysis of a therapeutic failure of L-Dopa: can Adams-Van Bosaert and Van Der Eecken's strio-nigral degeneration be diagnosed during the patient's life?].
    André JM, Royer RJ, Duc M, Kissel P.
    Rev Neurol (Paris); 1974 Aug 21; 130(7-8):322-6. PubMed ID: 4453761
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Levodopa treatment of Parkinson's syndrome: past and future.
    Pletscher A.
    Adv Neurol; 1990 Aug 21; 53():469-73. PubMed ID: 2239486
    [No Abstract] [Full Text] [Related]

  • 34. [Results of prolonged treatment of Parkinson's disease with the L-dopa-benserazide combination].
    Casacchia M, Barba C, Ruggieri S, Zamponi A, Agnoli A.
    Riv Neurol; 1974 Aug 21; 44(5):303-30. PubMed ID: 4217465
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Response to Sinemet 25/100 in Parkinson's disease.
    Ulm G, Gerdes U, Lehmann K.
    Adv Neurol; 1984 Aug 21; 40():541-7. PubMed ID: 6695634
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.